Roche Holding AG Website

Roche Holding AG

OTCPK-RHHB.Y

Basic

  • Market Cap

    $196.62B

  • EV

    $223.33B

  • Shares Out

    797.24M

  • Revenue

    CHF 60.44B

  • Employees

    103,605

Margins

  • Gross

    74.19%

  • EBITDA

    34.61%

  • Operating

    29.42%

  • Pre-Tax

    23.29%

  • Net

    19.02%

  • FCF

    20.44%

Returns (5Yr Avg)

  • ROA

    15.29%

  • ROTA

    58.23%

  • ROE

    38.9%

  • ROCE

    34.19%

  • ROIC

    24.07%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $40.59

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    CHF 10.51B

  • Net Debt

    CHF 20.34B

  • Debt/Equity

    0.93

  • EBIT/Interest

    21.47

Growth (CAGR)

  • Rev 3Yr

    0.05%

  • Rev 5Yr

    0.32%

  • Rev 10Yr

    2.2%

  • Dil EPS 3Yr

    -4.68%

  • Dil EPS 5Yr

    3.23%

  • Dil EPS 10Yr

    1.02%

  • Rev Fwd 2Yr

    3.9%

  • EBITDA Fwd 2Yr

    5.52%

  • EPS Fwd 2Yr

    2.56%

  • EPS LT Growth Est

    4.89%

Dividends

  • Yield

    —

  • Payout

    66.71%

  • DPS

    CHF 9.6

  • DPS Growth 3Yr

    1.8%

  • DPS Growth 5Yr

    1.99%

  • DPS Growth 10Yr

    2.1%

  • DPS Growth Fwd 2Yr

    5.87%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23

Operating Revenues

63,751

60,343

65,850

63,281

58,716

Other Revenues, Total

—

—

—

—

—

—

—

—

2,533

1,725

Total Revenues

63,751

60,343

65,850

65,814

60,441

Total Revenues % Chg.

7.1%

-5.3%

9.1%

-0.1%

-8.2%

Cost of Goods Sold, Total

17,385

15,861

19,360

17,938

15,597

Gross Profit

46,366

44,482

46,490

47,876

44,844

Selling General & Admin Expenses, Total

13,183

11,954

11,977

13,691

13,486

R&D Expenses

11,923

12,566

14,022

13,599

13,545

Other Operating Expenses

—

227

265

238

17

34

Other Operating Expenses, Total

25,333

24,785

26,237

27,307

27,065

Operating Income

21,033

19,697

20,253

20,569

17,779

Interest Expense, Total

-620

-438

-342

-608

-828

Interest And Investment Income

100

16

—

40

195

Net Interest Expenses

-520

-422

-342

-568

-633

Income (Loss) On Equity Invest.

—

—

—

-15

-1

-2

-41

-32

Currency Exchange Gains (Loss)

-205

-206

-232

-278

-243

Other Non Operating Income (Expenses)

-24

2

5

-90

-14

EBT, Excl. Unusual Items

20,269

19,070

19,682

19,592

16,857

Restructuring Charges

-1,248

-909

-1,362

-969

-2,038

Merger & Related Restructuring Charges

43

-9

-57

38

-25

Impairment of Goodwill

—

-779

-247

—

—

-591

Gain (Loss) On Sale Of Investments

189

171

-89

-85

5

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

—

—

618

569

Asset Writedown

-1,219

-435

-634

-2,869

-637

Legal Settlements

—

—

—

—

—

-422

338

-122

45

172

Other Unusual Items

-219

-14

-20

-43

-233

EBT, Incl. Unusual Items

16,614

17,965

17,398

16,327

14,079

Income Tax Expense

2,506

2,897

2,463

2,796

1,721

Earnings From Continuing Operations

14,108

15,068

14,935

13,531

12,358

Minority Interest

-611

-773

-1,005

-1,110

-860

Net Income

13,497

14,295

13,930

12,421

11,498

Net Income to Common Incl Extra Items

13,497

14,295

13,930

12,421

11,498

Net Income to Common Excl. Extra Items

13,497

14,295

13,930

12,421

11,498

Total Shares Outstanding

852

853.1

800.4

799.2

797.2

Weighted Avg. Shares Outstanding

856

855

850

800

799

Weighted Avg. Shares Outstanding Dil

864

865

860

808

804

EPS

15.8

16.7

16.4

15.5

14.4

EPS Diluted

15.6

16.5

16.2

15.4

14.3

EBITDA

24,974

23,898

24,333

24,072

20,918

Effective Tax Rate

15.1%

16.1%

14.2%

17.1%

12.2%